Learn More
Medchemexpress LLC Enterolactone | 78473-71-9 | 98.2% | 298.33 | 50 MG

Supplier: Medchemexpress LLC HY108692500UG
Enterolactone is a bioactive phenolic metabolite and mammalian lignan derived from dietary lignans. It possesses estrogenic properties and exhibits anti-breast cancer activity, acting as a radiosensitizer for human breast cancer cell lines by impairing DNA repair and increasing apoptosis.
- Possesses estrogenic properties.
- Exhibits anti-breast cancer activity.
- Acts as a radiosensitizer for human breast cancer cell lines.
- Arrests the growth of MDA-MB-231 breast cancer cells in the 'S' phase.
- Triggers apoptosis in MDA-MB-231 breast cancer cells via caspase-3 activation.
- Inhibits TGF-β-induced migration and invasion of MDA-MB-231 breast cancer cells.
- Inhibits the TGF-β-induced EMT program in MDA-MB-231 breast cancer cells.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.